Outcome Not Affected by Family Presence During Resuscitation

This article originally appeared here.
Share this content:
Outcome Not Affected by Family Presence During Resuscitation
Outcome Not Affected by Family Presence During Resuscitation

WEDNESDAY, March 25, 2015 (HealthDay News) -- There are no significant differences in outcomes or processes of care for U.S. hospitals with policies allowing for family presence during resuscitation (FPDR) compared with hospitals without this policy, according to a study published online March 24 in Circulation: Cardiovascular Quality and Outcomes.

Zachary D. Goldberger, M.D., from the University of Washington in Seattle, and colleagues examined the overall safety of FPDR policies and their impact on resuscitation care. An observational cohort study was conducted in 252 U.S. hospitals involving 41,568 adults with cardiac arrest.

The researchers found that facility characteristics did not differ significantly for hospitals with versus those without an FPDR policy. There were also no significant differences between hospitals with versus without FPDR policies in the return of spontaneous circulation (adjusted risk ratio, 1.02; 95 percent confidence interval, 0.95 to 1.06) or in survival to discharge (adjusted risk ratio, 1.05; 95 percent confidence interval, 0.95 to 1.15). A small, borderline decrease in the mean time to defibrillation was seen at hospitals with versus those without an FPDR policy (mean difference, 0.32 minutes). There was no meaningful difference between hospitals with and those without an FPDR policy in terms of resuscitation quality, interventions, and facility-reported potential resuscitation systems errors.

"Further study is warranted about the direct effect of FPDR attempts on adult patients with an in-hospital cardiac arrest and their families," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »